Drug intelligence / Profile preview

trolamine emulsion

Development stage: Unknown
Lead developer: Ortho Dermatologics
Modality: Drug Delivery Systems, Small Molecules
Administration: Topical

Overview

Biafine is a water-based emulsion formulated for the dressing and management of superficial wounds, minor abrasions, dermal ulcers, donor sites, 1st and 2nd degree burns (including sunburns), and radiation dermatitis. When applied properly to a wound, Biafine provides an optimum moist environment for the healing process. It contains ingredients like paraffin, squalane, and avocado oil that provide occlusive properties, hydration, and skin-soothing benefits. The active ingredient trolamine (0.670 g per 100 g emulsion) works as an emollient to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations.

Brand names: BiafineBiafine RE
Other names: Biafine Topical EmulsionBiafine Wound Dressing

Beyond the preview

Go deeper on trolamine emulsion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on trolamine emulsion.

Explore the full profile